Migration and invasion inhibitory protein [MIIP, also known as IIp45] was initially identified as a binding partner of insulin-like growth factor-binding protein 2 (IGFBP2) and a negative regulator of cell invasion in glioma [18]. Here, IGFBP2 is linked to central nervous system cancer.